Alibaba Health Information Technology Limited

SEHK:241 Stock Report

Market Cap: HK$49.2b

Alibaba Health Information Technology Past Earnings Performance

Past criteria checks 5/6

Alibaba Health Information Technology has been growing earnings at an average annual rate of 48.4%, while the Consumer Retailing industry saw earnings growing at 31.5% annually. Revenues have been growing at an average rate of 33.7% per year. Alibaba Health Information Technology's return on equity is 5.1%, and it has net margins of 2.9%.

Key information

48.4%

Earnings growth rate

48.4%

EPS growth rate

Consumer Retailing Industry Growth28.3%
Revenue growth rate33.7%
Return on equity5.1%
Net Margin2.9%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Apr 21
Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Apr 16
Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Mar 29
Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

Mar 12
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Jan 17
With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Jan 07
Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Dec 15
Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Sep 28
Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Jul 02
Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Jun 11
Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Jun 22
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Dec 01
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Oct 15
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Aug 12
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

Jun 25
Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

May 30
These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

May 27
Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Mar 23
The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

Mar 05
Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Feb 15
How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 31
Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Dec 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 16
Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

Dec 01
Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

Revenue & Expenses Breakdown
Beta

How Alibaba Health Information Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:241 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2328,2188175,336673
30 Jun 2327,4916755,196675
31 Mar 2326,7635335,055678
31 Dec 2224,7423324,701704
30 Sep 2222,7201284,346730
30 Jun 2221,649-694,410729
31 Mar 2220,578-2664,474729
31 Dec 2119,146-2164,171623
30 Sep 2117,714-1673,868517
30 Jun 2116,616913,501470
31 Mar 2115,5183493,135424
31 Dec 2014,0803132,836385
30 Sep 2012,6422782,537347
30 Jun 2011,1191362,289300
31 Mar 209,596-72,041253
31 Dec 198,465-31,833252
30 Sep 197,33411,624250
30 Jun 196,215-401,416235
31 Mar 195,096-821,208219
31 Dec 184,264-911,034194
30 Sep 183,432-100859169
30 Jun 182,937-104760147
31 Mar 182,443-107661126
31 Dec 171,876-152563123
30 Sep 171,310-196465120
30 Jun 17892-202371114
31 Mar 17475-208276109
31 Dec 16285-20123399
30 Sep 1694-19419190
30 Jun 1676-19318283
31 Mar 1657-19217376
31 Dec 1544-17317568
30 Sep 1532-15417760
30 Jun 1531-11814547
31 Mar 1530-8111334
31 Dec 1431-607429
30 Sep 1431-393523
30 Jun 1427-363519
31 Mar 1422-313314
31 Dec 1316-35347
30 Sep 1312-39360
30 Jun 1312-36340

Quality Earnings: 241 has high quality earnings.

Growing Profit Margin: 241's current net profit margins (2.9%) are higher than last year (0.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 241 has become profitable over the past 5 years, growing earnings by 48.4% per year.

Accelerating Growth: 241's earnings growth over the past year (536.3%) exceeds its 5-year average (48.4% per year).

Earnings vs Industry: 241 earnings growth over the past year (536.3%) exceeded the Consumer Retailing industry 3.1%.


Return on Equity

High ROE: 241's Return on Equity (5.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.